Specialist pharma consulting. Make it. Prove it. Own it.
Brendan Walsh · Principal
Schedule a ConversationWhat We Do
Make It
Formulation science, process engineering, scale-up, and tech transfer. We bring three decades of hands-on pharma expertise to the product and process challenges that determine whether a drug gets made, and made reliably. Oral solid dose, nasal sprays, topicals, liquids, semi-solids. OTC, Rx, dietary supplements, medical devices.
Prove It
Validation, GxP, QbD, and regulatory readiness. Getting the product to work is only half the job. We make sure the process holds up under scrutiny. FDA Pre-Approval Inspections, process validation strategy, technical risk assessment, and CMC support.
Own It
Quality systems, data architecture, and regulatory documentation. We help organisations build the infrastructure that makes compliance sustainable, not a one-time effort but an embedded capability. Enterprise quality systems, laboratory informatics, PLM and specification data management, technical standards and SOPs.
Who We Work With
We work with a select group of clients where the technical stakes are high and generalist hours aren't enough.
You have the science. We bring the institutional knowledge that comes from decades of doing this at scale. The scale-up experience, the process robustness, the regulatory judgment that only comes from having been there before.
Technical due diligence on pharma manufacturing assets and product portfolios. We answer the question that financial diligence can't: is this asset what it claims to be? Technical Due Diligence is available as a standalone engagement.
Pharma technical SME support for GMP facility builds. CQV strategy, IQ/OQ/PQ programme leadership, process validation, schedule integration, and regulatory milestone definition for GxP facilities.
Peer-level collaboration for engagements that need specialist bench depth. Formulation, process, validation, brought in where the expertise is needed most.
Market Intelligence
An ongoing intelligence platform tracking ingredient trends, evidence quality, regulatory signals, and competitive moves across three consumer health verticals. Each vertical delivers a trend radar, monthly pulse, white space analysis, and regulatory alerts.
Vitamins & minerals, gut health, nootropics, beauty & longevity, and women's health. 31 ingredients tracked across five segments.
Claim landscape, reformulation signals, Rx-to-OTC pipeline, and competitive brand moves across four therapeutic segments.
Ingredient innovation, clinical evidence, and regulatory positioning across five oral health segments. Fluoride, hydroxyapatite, and the microbiome.
Trend radar · Monthly pulse · White space analysis · Regulatory alerts. Access requires a brief registration.
About
The Ballymote Group is built on three decades of pharmaceutical and consumer healthcare experience, from SmithKline Beecham through GSK to Haleon. Past engagements include leading multiple Rx-to-OTC switch projects, delivering a first-in-kind QbD NDA submission, and earning a President's Award for supply chain crisis mitigation.
Additional experience includes successfully defending novel regulatory methodology to FDA auditors during Pre-Approval Inspections, and resolving post-launch product issues before they became compliance events.
The name comes from Ballymote, the Walsh family's ancestral town in County Sligo, Ireland. It's also the name of our house. The home base, literal and figurative, of the practice.
We help smaller pharma companies and investors avoid the product and process mistakes that derail drugs and deals. If you've been pointed this way by someone you trust, we'd be glad to talk.
Brendan Walsh
Contact
If you've been pointed this way by someone you trust,
we'd be glad to hear from you.
The Ballymote Group LLC
Blairstown, New Jersey